Cargando…
Rivaroxaban-associated intracranial hemorrhage in Saudi atrial fibrillation patients
Atrial fibrillation is the most common cardiac arrhythmia. Anticoagulation therapy effectively reduces systemic embolization in patients with non-valvular atrial fibrillation, but intracranial hemorrhage (ICH) is a major possible complication. This study assessed the real-time rate of rivaroxaban-as...
Autores principales: | Alkhotani, Amal, Alrishi, Nouf, Alharthi, Meshari, Alzahrani, Waleed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710243/ https://www.ncbi.nlm.nih.gov/pubmed/33235091 http://dx.doi.org/10.1097/MD.0000000000023316 |
Ejemplares similares
-
A case report of parenchymal hematoma after intravenous thrombolysis in a rivaroxaban-treated patient: Is it a true rivaroxaban hemorrhagic complication?
por: Rota, Eugenia, et al.
Publicado: (2017) -
Cauda Equina Syndrome Secondary to Leptomeningeal Carcinomatosis of Gastroesophageal Junction Cancer
por: Alkhotani, Amal, et al.
Publicado: (2016) -
Intraventricular hemorrhage caused by intracranial venous sinus thrombosis: Case report
por: Zhang, Hongbo, et al.
Publicado: (2016) -
Hemorrhagic pericarditis associated with rivaroxaban in an atrial fibrillation patient with pacemaker
por: Rhew, Shi Hyun, et al.
Publicado: (2017) -
Effect of statin use on clinical outcomes in ischemic stroke patients with atrial fibrillation
por: Wu, Yi-Ling, et al.
Publicado: (2017)